Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate MDI in Persistent Asthma
NCT01026870Phase 3Withdrawn
- Sponsor
- Organon & Co.
- Start
- Jun 2012
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of mometasone in asthma, sponsored by Organon & Co.. Planned start Jun 2012; status: withdrawn.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01026870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026870.